These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15149331)
21. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells. Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399 [TBL] [Abstract][Full Text] [Related]
22. Evidence for the role of active oxygen in guanidine synthesis in haemodialysis patients and in vitro. Nagase S; Aoyagi K; Sakamoto M; Narita M; Tojo S Nephrol Dial Transplant; 1988; 3(6):790-4. PubMed ID: 3147421 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein. Wang W; Alpert E Hepatology; 1995 Sep; 22(3):921-8. PubMed ID: 7544757 [TBL] [Abstract][Full Text] [Related]
24. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Schepers E; Glorieux G; Dou L; Cerini C; Gayrard N; Louvet L; Maugard C; Preus P; Rodriguez-Ortiz M; Argiles A; Brunet P; Cohen G; Jankowski J; Jankowski V; Massy Z; Rodriguez M; Vanholder R; Blood Purif; 2010; 30(4):277-87. PubMed ID: 21079396 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of neutrophil superoxide production by uremic concentrations of guanidino compounds. Hirayama A; Noronha-Dutra AA; Gordge MP; Neild GH; Hothersall JS J Am Soc Nephrol; 2000 Apr; 11(4):684-689. PubMed ID: 10752527 [TBL] [Abstract][Full Text] [Related]
35. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113 [TBL] [Abstract][Full Text] [Related]
36. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. Shah SV; Wallin JD; Eilen SD J Clin Endocrinol Metab; 1983 Aug; 57(2):402-9. PubMed ID: 6306042 [TBL] [Abstract][Full Text] [Related]
37. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Panichi V; De Pietro S; Andreini B; Bianchi AM; Migliori M; Taccola D; Giovannini L; Tetta C; Palla R Kidney Int; 1998 Nov; 54(5):1463-9. PubMed ID: 9844122 [TBL] [Abstract][Full Text] [Related]
38. [Effect of methylguanidine and guanidine succinic acid on methemoglobin reductase activity in human red cells]. Kopczyński Z; Dryl-Rydzyńska T Pol Tyg Lek; 1991 Feb 4-11; 46(6-7):140-2. PubMed ID: 1845732 [TBL] [Abstract][Full Text] [Related]
39. Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery--attenuating effect of cetraxate. Kurose I; Suematsu M; Miura S; Fukumura D; Sekizuka E; Nagata H; Oshio C; Tsuchiya M Toxicol Appl Pharmacol; 1993 May; 120(1):37-44. PubMed ID: 8511781 [TBL] [Abstract][Full Text] [Related]
40. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Schepers E; Meert N; Glorieux G; Goeman J; Van der Eycken J; Vanholder R Nephrol Dial Transplant; 2007 Feb; 22(2):592-6. PubMed ID: 17040995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]